OMALIZUMAB
omalizumab 150 mg/mL injection, 1 mL pen device
OMALIZUMAB (14945N)
14945N
Manner of administration:Injection
Restriction
Indication: Severe chronic spontaneous urticaria
Treatment phase: Initial treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 2 | # of repeats: 2 | DPMQ: $418.14 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||